Loading…
Lobbying Spend
—
Filings
12
Firms Hired
1
Active Period
2022–2026
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Food and Drug Amendments of 2022
2022 · fourth_quarter · Firm: W STRATEGIES, LLC
Education around innovation in neurological rare disease. S.4348: FDASLA Act of 2022 and H.R.7667: Food and Drug Amendments of 2022.
Client expense: — · Firm income: $30,000
Matched citations: H.R.7667
Education around innovation in neurological rare disease. S.4348: FDASLA Act of 2022 and H.R.7667: Food and Drug Amendments of 2022.
Client expense: — · Firm income: $30,000
Matched citations: S.4348
Food and Drug Amendments of 2022
2022 · third_quarter · Firm: W STRATEGIES, LLC
Education around innovation in neurological rare disease. S.4348: FDASLA Act of 2022 and H.R.7667: Food and Drug Amendments of 2022.
Client expense: — · Firm income: $30,000
Matched citations: H.R.7667
Education around innovation in neurological rare disease. S.4348: FDASLA Act of 2022 and H.R.7667: Food and Drug Amendments of 2022.
Client expense: — · Firm income: $30,000
Matched citations: S.4348
Food and Drug Amendments of 2022
2022 · second_quarter · Firm: W STRATEGIES, LLC
Education around innovation in neurological rare disease. S.4348: FDASLA Act of 2022 and H.R.7667: Food and Drug Amendments of 2022.
Client expense: — · Firm income: $30,000
Matched citations: H.R.7667
Education around innovation in neurological rare disease. S.4348: FDASLA Act of 2022 and H.R.7667: Food and Drug Amendments of 2022.
Client expense: — · Firm income: $30,000
Matched citations: S.4348
Source: Senate LDA